CD86 and neoplasm: During the development of PDAC, the expression levels of the maturation marker MHC-II and the co-stimulatory molecules CD40 and CD86 on tumor-associated DCs decrease, which can be attributed to an increase in IL-6,150 of which M2-like TAMs are an important source.87